Skip Navigation or Skip to Content
LATEST NEWS:
Join us at Biomanufacturing World Summit November 19-21 Read more »
Contact Us

Insights

Home > Insights & Case Studies > How MES Helps Solve The Top 5 Challenges in Biomanufacturing

How MES Helps Solve The Top 5 Challenges in Biomanufacturing

Biomanufacturing thrives as personalized medicine, biologics, and cutting-edge therapies reshape modern healthcare. While the growth prospects are extraordinary, the journey is complex. Biomanufacturers face immense pressures to scale quickly, manage multi-tiered supply chains, and navigate rigorous regulatory frameworks, all while keeping costs in check and addressing workforce gaps.

Manufacturing Execution Systems (MES) are pivotal in helping biomanufacturers overcome these challenges by integrating real-time monitoring, optimizing workflows, and providing actionable data. In this article, we’ll explore biomanufacturing’s top five challenges and discuss how MES helps tackle them with specific case studies and industry insights.

 

1. Scalability and Flexibility

The biologics market is projected to reach $375 billion by 2025, intensifying the need for scalable production solutions. Unlike traditional pharmaceuticals, biologics require precise control over complex, living-cell processes, making scalability a significant challenge. Transitioning from small-batch clinical production to large-scale commercial manufacturing demands flexibility and precision, as even minor inconsistencies can jeopardize product quality and compliance.

 

In-Depth Case Study – Moderna’s Agile Response to COVID-19 Demand

During the COVID-19 pandemic, Moderna’s task was unprecedented: ramping up from zero production to over 800 million doses in a year. To achieve this 2,000% production increase, Moderna leveraged MES to create a fully digital, agile manufacturing environment. They integrated single-use bioreactors to minimize contamination risks, and MES provided real-time tracking across each production stage. This allowed Moderna to adapt quickly, switching batch recipes and adjusting parameters based on quality control feedback without halting production.

 

How MES Enables Scalability

MES ensures real-time data integrity, providing relief by enabling companies to react swiftly to production demands. For instance, MES allows biomanufacturers to scale up by providing batch record automation and built-in flexibility for handling recipe modifications. It also enables parallel monitoring across multiple production lines, ensuring that scale-up efforts do not compromise product quality—a crucial factor when moving to a commercial scale.

 

2. Supply Chain Complexity

Supply chain disruptions have become a top risk in biomanufacturing, with 63% of companies reporting production issues due to material shortages and delays. The reliance on specialized raw materials—often with limited suppliers—further complicates this challenge. COVID-19 exacerbated these vulnerabilities, and manufacturers increasingly look to MES to mitigate risks and create a more resilient supply chain.

 

In-Depth Case Study – Pfizer’s MES-Driven Supply Chain Resilience

In their race to produce the COVID-19 vaccine, Pfizer faced significant supply chain challenges, particularly with lipid nanoparticles crucial for mRNA stability. MES, integrated with Pfizer’s ERP system, allowed for end-to-end visibility of raw materials, tracking everything from inventory levels to supplier performance. This data integration enabled Pfizer to anticipate shortages, secure alternative suppliers, and adjust production schedules without significant delays. The real-time tracking capability also allowed Pfizer to manage inventory efficiently, reduce waste, and avoid production stoppages.

 

How MES Optimizes Supply Chain Management

By integrating MES with ERP, biomanufacturers gain real-time visibility into material availability and supplier performance, empowering them to proactively manage stockouts and track every batch from supplier to production. MES can also identify patterns in supplier delays or quality issues, enabling data-driven decisions on alternative sourcing. Furthermore, MES can simulate production scenarios, helping companies to foresee supply risks and prepare accordingly.

 

3. Regulatory Compliance

Biomanufacturing is one of the most tightly regulated industries, especially for therapies involving live cells or gene modifications. Maintaining stringent regulatory compliance (e.g., FDA’s GMP) and accurately documenting every process step is essential to avoid production delays, regulatory setbacks, and costly recalls. The complexity of these requirements makes traditional paper-based documentation increasingly unfeasible, driving the need for automated systems.

 

In-Depth Case Study – Sarepta Therapeutics and Automated Compliance

Sarepta Therapeutics, a gene therapy leader, used MES to transition to automated compliance, reducing documentation time by 30% and minimizing manual data entry errors. Before MES implementation, ensuring data integrity and accuracy was time-intensive, delaying regulatory submissions. With MES, Sarepta streamlined data capture and batch record management, ensuring compliance with FDA requirements and reducing the risk of batch rejections. MES also enabled Sarepta to meet audit standards effortlessly, enhancing overall process transparency and reliability.

 

How MES Facilitates Compliance

MES simplifies compliance by automating data capture for batch records, quality control, and traceability. It ensures that all production data are accurately recorded in real time, creating a digital audit trail that can be accessed quickly for regulatory inspections. With built-in GMP workflows, MES can enforce process controls and alert operators to deviations immediately, instilling confidence in manufacturers to address quality issues proactively.

 

4. Cost Management

Producing biologics is resource-intensive, with costs exceeding those of small-molecule drugs by up to 100 times. The need for sterile environments, specialized equipment, and highly controlled processes drives production costs, making operational efficiency critical for profitability. Biomanufacturers are increasingly adopting MES to enhance productivity and reduce waste.

 

In-Depth Case Study – Amgen’s Shift to Continuous Bioprocessing

To cut production costs, Amgen implemented continuous bioprocessing with the support of MES, achieving a 50% reduction in manufacturing expenses. Amgen could reduce downtime, optimize batch cycle times, and increase yield by moving from batch-based production to a continuous flow model. MES enabled real-time adjustments to process parameters, enhancing Overall Equipment Effectiveness (OEE) and reducing waste. This shift saved Amgen nearly $200 million annually, underscoring the cost-saving potential of MES-driven continuous processing.

How MES Drives Cost Efficiency

MES improves cost management by enabling continuous monitoring and optimization of production cycles. It reduces the need for excess inventory and minimizes energy consumption, which can be a substantial expense in biomanufacturing. By enhancing OEE and streamlining production workflows, MES allows manufacturers to maximize resource utilization, lower operational costs, and improve profitability.

5. Workforce and Expertise Gaps

The biomanufacturing industry faces a critical shortage of skilled talent, particularly in specialized areas like cell and gene therapy production. As manufacturing processes become more complex, the demand for trained personnel with technical and digital skills intensifies. MES helps bridge this gap by standardizing processes and providing real-time guidance for less experienced operators.

 

In-Depth Case Study – Cytiva’s Approach to Workforce Development

Cytiva, a primary bioprocessing technology provider, addressed workforce gaps by combining MES with digital training programs. Through MES, Cytiva standardized procedures and provided digital work instructions, which guided operators through complex tasks step-by-step. This approach reduced training time by 25% and minimized errors, allowing Cytiva to maintain production quality even with a less experienced workforce.

 

How MES Supports Workforce Optimization

MES systems provide a standardized workflow framework, ensuring consistency in production processes regardless of operator experience. By embedding step-by-step digital instructions, MES allows employees to complete tasks more accurately, reducing the dependency on specialized skills. Additionally, MES can track and analyze operator performance, helping companies identify skill gaps and design targeted training programs.

 

“Bonus” Challenge: The Rise of Digital Twins

The concept of digital twins, virtual replicas of physical production processes, is transforming biomanufacturing. Digital twins enable companies to simulate and optimize production processes, test changes, and predict outcomes before implementing them in natural environments. This technology relies heavily on MES, which provides the real-time data required for accurate simulation.

 

In-Depth Case Study – Pfizer’s Digital Twin for COVID-19 Vaccine Production

Pfizer collaborated with Siemens to create a digital twin for its COVID-19 vaccine production line. By simulating the production process, Pfizer could identify bottlenecks and optimize workflows, increasing yield by 15% without altering the physical production line. MES provided the real-time data necessary to build an accurate digital twin, allowing Pfizer to rapidly test process changes and make informed decisions.

 

How MES Enables Digital Twins

MES serves as the data backbone for digital twins, feeding accurate, real-time information to virtual simulations. This enables manufacturers to experiment with process adjustments, troubleshoot issues, and assess potential improvements without disrupting production. Digital twins offer a powerful tool for process optimization, reducing downtime, and enhancing overall manufacturing flexibility.

 

Wrapping It Up

Biomanufacturing’s rapid evolution is a testament to the power of technological innovation, yet the journey is complex and challenging. Each challenge requires a strategic approach, from scalability and supply chain management to regulatory compliance, cost control, and workforce limitations. MES has emerged as a critical enabler, allowing biomanufacturers to streamline operations, enhance process visibility, and effectively meet regulatory standards.

As the industry progresses toward digitalization with digital twins and continuous bioprocessing technologies, MES will remain essential for driving efficiency, scalability, and compliance in biomanufacturing. By leveraging MES, companies can transform these challenges into opportunities, ultimately advancing the delivery of life-saving therapies to patients worldwide.

References

Let's Talk

In this age of new biotech discoveries, the challenges are everywhere – but so are the opportunities and solutions. Let’s talk about where you want to take your innovations.

Contact us
« Back to Insights